Azlocillin - Flightpath Biosciences
Alternative Names: FP-101 - Flightpath BiosciencesLatest Information Update: 10 Oct 2023
At a glance
- Originator Flightpath Biosciences
- Class Antibacterials; Penicillins; Small molecules
- Mechanism of Action Cell wall inhibitors; Penicillin-binding protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Lyme disease
Most Recent Events
- 10 Oct 2023 Discontinued - Preclinical for Lyme disease in USA (PO) (Flightpath Biosciences website, October 2023)
- 11 Feb 2021 Preclinical trials in Lyme disease in USA (PO), prior to February 2021 (Flightpath Biosciences pipeline, February 2021)